We are live on ! Find out more
CIA

CSat Investment Advisory Portfolio holdings

AUM $119M
1-Year Est. Return 77.51%
This Fund
S&P 500
This Quarter Est. Return
+0.91%
1 Year Est. Return
+77.51%
3 Year Est. Return
+87.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$318M
AUM Growth
+$35M
Cap. Flow
+$33.3M
Cap. Flow %
10.46%
Top 10 Hldgs %
39.42%
Holding
1,085
New
8
Increased
893
Reduced
156
Closed
17

Top Buys

Rank Stock Value
1
NTES icon
NetEase
NTES
+$1.34M
2
AMTD
TD Ameritrade Holding Corp
AMTD
+$1.31M
3
HPQ icon
HP
HPQ
+$1.17M
4
ICE icon
Intercontinental Exchange
ICE
+$973K
5
META icon
Meta Platforms (Facebook)
META
+$641K

Top Sells

Rank Stock Value
1
BBBY
Bed Bath & Beyond
BBBY
+$2.93M
2
INTC icon
Intel
INTC
+$1.32M
3
XNET
Xunlei
XNET
+$1.05M
4
HSY icon
Hershey
HSY
+$684K
5
JD icon
JD.com
JD
+$632K

Sector Composition

Rank Sector Weight
1 Technology 14.95%
2 Financials 13.94%
3 Consumer Discretionary 10.46%
4 Communication Services 10.06%
5 Industrials 5.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INFO
326
DELISTED
IHS Markit Ltd. Common Shares
INFO
$96K 0.03%
1,428
+57
+4% +$3.73K
CARG icon
327
CarGurus
CARG
$3.47B
$95K 0.03%
3,055
+559
+22% +$19K
LYB icon
328
LyondellBasell Industries
LYB
$19.2B
$95K 0.03%
1,057
+187
+21% +$15.2K
WM icon
329
Waste Management
WM
$91B
$95K 0.03%
823
+78
+10% +$9.11K
GAP
330
The Gap Inc
GAP
$7.37B
$95K 0.03%
5,469
-8,440
-61% -$150K
OKE icon
331
Oneok
OKE
$54.5B
$94K 0.03%
1,280
+81
+7% +$5.73K
PLD icon
332
Prologis
PLD
$133B
$94K 0.03%
1,111
+96
+9% +$7.94K
RARE icon
333
Ultragenyx Pharmaceutical
RARE
$2.55B
$94K 0.03%
2,191
+390
+22% +$21.2K
REGN icon
334
Regeneron Pharmaceuticals
REGN
$80.8B
$93K 0.03%
334
+39
+13% +$11.5K
BNY
335
Bank of New York Mellon
BNY
$107B
$92K 0.03%
2,047
+216
+12% +$9.62K
CPRI icon
336
Capri Holdings
CPRI
$1.74B
$92K 0.03%
2,769
+681
+33% +$21.8K
CI icon
337
Cigna
CI
$74.6B
$91K 0.03%
601
+63
+12% +$10.3K
SPG icon
338
Simon Property Group
SPG
$72.3B
$91K 0.03%
584
+83
+17% +$12.9K
APD icon
339
Air Products & Chemicals
APD
$67.6B
$89K 0.03%
399
+53
+15% +$11.9K
EMR icon
340
Emerson Electric
EMR
$88.3B
$89K 0.03%
1,327
+141
+12% +$8.86K
GPN icon
341
Global Payments
GPN
$22.8B
$89K 0.03%
556
+235
+73% +$38.4K
ROP icon
342
Roper Technologies
ROP
$39.8B
$88K 0.03%
247
+21
+9% +$7.63K
AMG icon
343
Affiliated Managers Group
AMG
$9.76B
$86K 0.03%
1,037
+190
+22% +$15.9K
GE icon
344
GE Aerospace
GE
$384B
$86K 0.03%
1,936
+223
+13% +$10.5K
LVS icon
345
Las Vegas Sands
LVS
$29.6B
$86K 0.03%
1,485
+156
+12% +$9.09K
PSA icon
346
Public Storage
PSA
$61.3B
$86K 0.03%
354
+55
+18% +$13.8K
ROST icon
347
Ross Stores
ROST
$81.9B
$86K 0.03%
782
+57
+8% +$6.01K
SLB icon
348
SLB Ltd
SLB
$75B
$86K 0.03%
2,507
+261
+12% +$9.54K
ALXN
349
DELISTED
Alexion Pharmaceuticals
ALXN
$86K 0.03%
877
+130
+17% +$14.7K
ANET icon
350
Arista Networks
ANET
$238B
$85K 0.03%
5,680
+288
+5% +$4.46K
12 13
14
15 16

Similar funds

FLSMF
Fundsmith Long/Short Master Fund Grand Cayman, Cayman Islands $121M AUM
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
IC
Investment Counsel Petoskey, Michigan $142M AUM 36.99% 1-Year Est. Return
BP
Banbury Partners Charlotte, North Carolina $161M AUM 78.27% 1-Year Est. Return
NI
Northwood Investors Denver, Colorado $73.8M AUM
EFM
Ennismore Fund Management London, United Kingdom $71.7M AUM 92.16% 1-Year Est. Return
WU
Wealthsimple US Brooklyn, New York $169M AUM 27.29% 1-Year Est. Return
EH
Employers Holdings Reno, Nevada $170M AUM 58.66% 1-Year Est. Return

CSat Investment Advisory's Q3 2019 Portfolio in Review

As of Q3 2019, CSat Investment Advisory held 1,085 positions worth $318M, up 12% from $283M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

CSat Investment Advisory deployed $33.3M of net new capital in Q3 2019, opening 8 new positions and adding to 893 existing holdings. Its largest new stake was Arena Pharmaceuticals Inc: 10,224 shares worth $468K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Bed Bath & Beyond, an estimated $2.93M trimmed.

  • CSat Investment Advisory's largest Q3 2019 buy was Arena Pharmaceuticals Inc: 10,224 shares worth $468K.
  • CSat Investment Advisory added most to NetEase in Q3 2019, an estimated $1.34M increase.
  • CSat Investment Advisory's biggest Q3 2019 reduction was Bed Bath & Beyond, cutting an estimated $2.93M.
  • CSat Investment Advisory fully exited Xunlei in Q3 2019, selling an estimated $1.05M.
  • CSat Investment Advisory's ten largest holdings make up 39% of its $318M portfolio in Q3 2019.
  • CSat Investment Advisory opened 8 new positions and closed 17 in Q3 2019.
  • CSat Investment Advisory's portfolio value rose 12% quarter-over-quarter to $318M.

Based on CSat Investment Advisory's 13F filing for Q3 2019, filed 14 Nov 2019.